UPAY (UPYY) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US9032121082
UPAY financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 715,269.00 USD | 746,311.00 USD |
| Gross profit | 444,363.00 USD | 547,510.00 USD |
| Operating income | -508,857.00 USD | -453,517.00 USD |
| EBIT | -508,857.00 USD | -1.36 m USD |
| Net income | -540,062.00 USD | -1.41 m USD |
| Diluted EPS – continuing operations | -0.03 USD | -0.08 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About UPAY
UPAY, Inc. provides a web-based client and loan administration software platform under the automated credit provider administration system (ACPAS) name to registered lenders in South Africa. It offers a cloud-based loan origination software system that enables customers to grant loans, sell products, pay bills, or pay monthly subscriptions on terms. The company also develops tailor-made web sites for customers. In addition, it resells credit bureau products; acts as an agent for a licensed insurer, and third-party payment provider for debit order transactions. Further, the company provides custom software development and administrative staffing services to customers. It serves customers with physical branch outlets, as well as online customers with lending websites. UPAY, Inc. was founded in 2009 and is based in Dallas, Texas.
More stocks
- Track Group, Inc. (TRCK)
- Cable One, Inc. (CABO)
- Picard Medical, Inc. (PMI)
- Jaguar Uranium Corp. (JAGU)
- Medalist Diversified, Inc. (MDRR)
- INTELLINETICS, INC. (INLX)
- RETRACTABLE TECHNOLOGIES INC (RVP)
- DYNARESOURCE, INC. (DYNR)
- Context Therapeutics Inc. (CNTX)
- REGIONAL HEALTH PROPERTIES, INC (RHEPB)
- Teads Holding Co. (TEAD)
- Cosmos Health Inc. (COSM)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.